Macrophages and neurodegeneration

Brain Research Reviews

Volumn 48, Issue 2, 2005, Pages 185-195

  Hendriks, Jerome J A ^a   Teunissen, Charlotte E ^a   De Vries, Helga E ^a   Dijkstra, Christine D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Axonal loss; Blood brain barrier; Experimental allergic encephalomyelitis (EAE); Macrophages; Monocyte migration; Multiple sclerosis; Neurodegeneration

Indexed keywords

AMINOGUANINE; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; BILIRUBIN; CALCIUM CHANNEL BLOCKING AGENT; CATALASE; CYTOKINE; FLAVONOID; FREE RADICAL; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; HEMOXYGENASE 1; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INTERLEUKIN 1; INTERLEUKIN 6; LUTEOLIN; METALLOPROTEINASE; METALLOTHIONEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGENASE; REACTIVE OXYGEN METABOLITE; SODIUM CHANNEL BLOCKING AGENT; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIC ACID;

ALLERGIC ENCEPHALOMYELITIS; CONFERENCE PAPER; DEMYELINATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TREATMENT OUTCOME;

EID: 17844381010     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2004.12.008     Document Type: Conference Paper

References (189)

1. A. Achiron, S. Miron, V. Lavie, R. Margalit, and A. Biegon Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis J. Neuroimmunol. 102 2000 26 31
2. A. Alcazar, I. Regidor, J. Masjuan, M. Salinas, and J.C. Alvarez-Cermeno Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis J. Neuroimmunol. 104 2000 58 67
3. D.C. Anthony, B. Ferguson, M.K. Matyzak, K.M. Miller, M.M. Esiri, and V.H. Perry Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke Neuropathol. Appl. Neurobiol. 23 1997 406 415
4. R.M. Arantes, S. Lourenssen, C.R. Machado, and M.G. Blennerhassett Early damage of sympathetic neurons after co-culture with macrophages: a model of neuronal injury in vitro NeuroReport 11 2000 177 181
5. O. Bagasra, F.H. Michaels, Y.M. Zheng, L.E. Bobroski, S.V. Spitsin, Z.F. Fu, R. Tawadros, and H. Koprowski Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 92 1995 12041 12045
6. D. Baker, D. Butler, B.J. Scallon, J.K. ONeill, J.L. Turk, and M. Feldmann Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins Eur. J. Immunol. 24 1994 2040 2048
7. V.P. Barkhatova, I.A. Zavalishin, L.S. Askarovafo, V.K. Shavratskii, and E.G. Demina Changes in neurotransmitters in multiple sclerosis Neurosci. Behav. Physiol. 28 1998 341 344
8. H.T. Besler, and S. Comoglu Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis Nutr. Neurosci. 6 2003 189 196
9. D.L. Birken, and W.H. Oldendorf N-acetyl-l-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain Neurosci. Biobehav. Rev. 13 1989 23 31
10. A. Bitsch, J. Schuchardt, S. Bunkowski, T. Kuhlmann, and W. Bruck Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation Brain 123 Pt. 6 2000 1174 1183
11. C. Bjartmar, J. Battistuta, N. Terada, E. Dupree, and B.D. Trapp N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve Ann. Neurol. 51 2002 51 58
12. C. Bjartmar, G. Kidd, S. Mork, R. Rudick, and B.D. Trapp Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients Ann. Neurol. 48 2000 893 901
13. J.A. Black, M. Renganathan, and S.G. Waxman Sodium channel Na(v)1.6 is expressed along nonmyelinated axons and it contributes to conduction Brain Res. Mol. Brain Res. 105 2002 19 28
14. L. Bo, T.M. Dawson, S. Wesselingh, S. Mork, S. Choi, P.A. Kong, D. Hanley, and B.D. Trapp Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains Ann. Neurol. 36 1994 778 786
15. L.M. Bolin, A.N. Verity, J.E. Silver, E.M. Shooter, and J.S. Abrams Interleukin-6 production by Schwann cells and induction in sciatic nerve injury J. Neurochem. 64 1995 850 858
16. H. Bostock, and T.A. Sears Continuous conduction in demyelinated mammalian nerve fibers Nature 263 1976 786 787
17. H. Bostock, and T.A. Sears The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination J. Physiol. 280 1978 273 301
18. H.M. Bramlett, S. Kraydieh, E.J. Green, and W.D. Dietrich Temporal and regional patterns of axonal damage following traumatic brain injury: a beta-amyloid precursor protein immunocytochemical study in rats J. Neuropathol. Exp. Neurol. 56 1997 1132 1141
19. W. Bruck, P. Porada, S. Poser, P. Rieckmann, F. Hanefeld, H.A. Kretzschmar, and H. Lassmann Monocyte/macrophage differentiation in early multiple sclerosis lesions Ann. Neurol. 38 1995 788 796
20. W. Bruck, N. Sommermeier, M. Bergmann, U. Zettl, H.H. Goebel, H.A. Kretzschmar, and H. Lassmann Macrophages in multiple sclerosis Immunobiology 195 1996 588 600
21. W. Bruck, A. Bitsch, H. Kolenda, Y. Bruck, M. Stiefel, and H. Lassmann Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology Ann. Neurol. 42 1997 783 793
22. B. Casanova, M.C. Martinez-Bisbal, C. Valero, B. Celda, L. Marti-Bonmati, A. Pascual, L. Landente, and F. Coret Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis: a HMRS study J. Neurol. 250 2003 22 28
23. A. Chakrabarty, M.R. Emerson, and S.M. LeVine Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis Mult. Scler. 9 2003 372 381
24. S. Chandler, R. Coates, A. Gearing, J. Lury, G. Wells, and E. Bone Matrix metalloproteinases degrade myelin basic protein Neurosci. Lett. 201 1995 223 226
25. C.C. Chao, and S. Hu Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures Dev. Neurosci. 16 1994 172 179
26. C.C. Chao, S. Hu, L. Ehrlich, and P.K. Peterson Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-d-aspartate receptors Brain Behav. Immun. 9 1995 355 365
27. C.C. Chao, S. Hu, W.S. Sheng, D. Bu, M.I. Bukrinsky, and P.K. Peterson Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism Glia 16 1996 276 284
28. M. Charcot Histologie de le sclerose en plaques Gazette Hopitaux 141 1868 554 558
29. D.W. Choi, J.Y. Koh, and S. Peters Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists J. Neurosci. 8 1988 185 196
30. M. Colasanti, and H. Suzuki The dual personality of NO Trends Pharmacol. Sci. 21 2000 249 252
31. M.J. Craner, Y. Kataoka, A.C. Lo, J.A. Black, D. Baker, and S.G. Waxman Temporal course of upregulation of Na(v)1.8 in Purkinje neurons parallels the progression of clinical deficit in experimental allergic encephalomyelitis J. Neuropathol. Exp. Neurol. 62 2003 968 975
32. M.J. Craner, A.C. Lo, J.A. Black, and S.G. Waxman Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination Brain 126 2003 1552 1561
33. M.J. Craner, B.C. Hains, A.C. Lo, J.A. Black, and S.G. Waxman Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE Brain 127 2004 294 303
34. M.L. Cuzner, D. Gveric, C. Strand, A.J. Loughlin, L. Paemen, G. Opdenakker, and J. Newcombe The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution J. Neuropathol. Exp. Neurol. 55 1996 1194 1204
35. C.M. Dalton, K.A. Miszkiel, G.J. Barker, D.G. MacManus, T.I. Pepple, M. Panzara, M. Yang, A. Hulme, P. OConnor, and D.H. Miller Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis J. Neurol. 251 2004 407 413
36. C.A. Davie, C.P. Hawkins, G.J. Barker, A. Brennan, P.S. Tofts, D.H. Miller, and W.I. McDonald Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions Brain 117 Pt. 1 1994 49 58
37. C.A. Davie, G.J. Barker, S. Webb, P.S. Tofts, A.J. Thompson, A.E. Harding, W.I. McDonald, and D.H. Miller Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss Brain 118 Pt. 6 1995 1583 1592
38. C.A. Davie, N.C. Silver, G.J. Barker, P.S. Tofts, A.J. Thompson, W.I. McDonald, and D.H. Miller Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J. Neurol. Neurosurg. Psychiatry 67 1999 710 715
39. C.J. De Groot, S.R. Ruuls, J.W. Theeuwes, C.D. Dijkstra, and P. van der Valk Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions J. Neuropathol. Exp. Neurol. 56 1997 10 20
40. C.J. De Groot, E. Bergers, W. Kamphorst, R. Ravid, C.H. Polman, F. Barkhof, and P. van der Valk Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions Brain 124 2001 1635 1645
41. N. De Stefano, P.M. Matthews, and D.L. Arnold Reversible decreases in N-acetylaspartate after acute brain injury Magn. Reson. Med. 34 1995 721 727
42. N. De Stefano, S. Narayanan, P.M. Matthews, G.S. Francis, J.P. Antel, and D.L. Arnold In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis Brain 122 Pt. 10 1999 1933 1939
43. N. De Stefano, S. Narayanan, G.S. Francis, R. Arnaoutelis, M.C. Tartaglia, J.P. Antel, P.M. Matthews, and D.L. Arnold Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability Arch. Neurol. 58 2001 65 70
44. N. De Stefano, S. Narayanan, S.J. Francis, S. Smith, M. Mortilla, M.C. Tartaglia, M.L. Bartolozzi, L. Guidi, A. Federico, and D.L. Arnold Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability Arch. Neurol. 59 2002 1565 1571
45. H.E. De Vries, J.J. Hendriks, H. Honing, C.R. De Lavalette, S.M. van der Pol, E. Hooijberg, C.D. Dijkstra, and T.K. van den Berg Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium J. Immunol. 168 2002 5832 5839
46. M.R. Emerson, and S.M. LeVine Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: an expanded view of the stress response J. Neurochem. 75 2000 2555 2562
47. A.G. Estevez, N. Spear, S.M. Manuel, L. Barbeito, R. Radi, and J.S. Beckman Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture Prog. Brain Res. 118 1998 269 280
48. N. Evangelou, D. Konz, M.M. Esiri, S. Smith, J. Palace, and P.M. Matthews Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis Brain 123 Pt. 9 2000 1845 1849
49. B. Ferguson, M.K. Matyszak, M.M. Esiri, and V.H. Perry Axonal damage in acute multiple sclerosis lesions Brain 120 Pt. 3 1997 393 399
50. M. Filippi Multiple sclerosis: a white matter disease with associated gray matter damage J. Neurol. Sci. 185 2001 3 4
51. S.M. Fine, R.A. Angel, S.W. Perry, L.G. Epstein, J.D. Rothstein, S. Dewhurst, and H.A. Gelbard Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia J. Biol. Chem. 271 1996 15303 15306
52. M.P. Flavin, K. Coughlin, and L.T. Ho Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons Neuroscience 80 1997 437 448
53. M.P. Flavin, G. Zhao, and L.T. Ho Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro Glia 29 2000 347 354
54. S. Floris, S.R. Ruuls, A. Wierinckx, S.M. van der Pol, E. Dopp, P.H. van der Meide, C.D. Dijkstra, and H.E. De Vries Interferon-beta directly influences monocyte infiltration into the central nervous system J. Neuroimmunol. 127 2002 69 79
55. R.E. Foster, C.C. Whalen, and S.G. Waxman Reorganization of the axon membrane in demyelinated peripheral nerve fibers: morphological evidence Science 210 1980 661 663
56. L. Fu, P.M. Matthews, N. De Stefano, K.J. Worsley, S. Narayanan, G.S. Francis, J.P. Antel, C. Wolfson, and D.L. Arnold Imaging axonal damage of normal-appearing white matter in multiple sclerosis Brain 121 Pt. 1 1998 103 113
57. R.A. Gadient, and U.H. Otten Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials Prog. Neurobiol. 52 1997 379 390
58. G. Garthwaite, D.A. Goodwin, S. Neale, D. Riddall, and J. Garthwaite Soluble guanylyl cyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition Mol. Pharmacol. 61 2002 97 104
59. S.M. Gentleman, M.J. Nash, C.J. Sweeting, D.I. Graham, and G.W. Roberts Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury Neurosci. Lett. 160 1993 139 144
60. J.J. Geurts, G. Wolswijk, L. Bo, P. van der Valk, C.H. Polman, D. Troost, and E. Aronica Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis Brain 126 2003 1755 1766
61. P. Ghezzi, and T. Mennini Tumor necrosis factor and motoneuronal degeneration: an open problem Neuroimmunomodulation 9 2001 178 182
62. K. Gijbels, P. Proost, S. Masure, H. Carton, A. Billiau, and G. Opdenakker Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein J. Neurosci. Res. 36 1993 432 440
63. Y. Gilgun-Sherki, H. Panet, E. Melamed, and D. Offen Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis Brain Res. 989 2003 196 204
64. Y. Gilgun-Sherki, E. Melamed, and D. Offen The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy J. Neurol. 251 2004 261 268
65. U. Gimsa, S.V. Peter, K. Lehmann, I. Bechmann, and R. Nitsch Axonal damage induced by invading T cells in organotypic central nervous system tissue in vitro: involvement of microglial cells Brain Pathol. 10 2000 365 377
66. G. Giovannoni Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis Mult. Scler. 4 1998 27 30
67. A. Glabinski, N.S. Tawsek, and G. Bartosz Increased generation of superoxide radicals in the blood of MS patients Acta Neurol. Scand. 88 1993 174 177
68. S. Gordon Alternative activation of macrophages Nat. Rev., Immunol. 3 2003 23 35
69. J.G. Greenfield, and L.S. King Observations on the histopathology of the cerebral lesions in disseminated sclerosis. Brain 59 1936 445 458
70. J. Grimaud, G.J. Barker, L. Wang, M. Lai, D.G. MacManus, S.L. Webb, A.J. Thompson, W.I. McDonald, P.S. Tofts, and D.H. Miller Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study J. Neurol. 246 1999 961 967
71. D.L. Gruol, and T.E. Nelson Physiological and pathological roles of interleukin-6 in the central nervous system Mol. Neurobiol. 15 1997 307 339
72. D. Gveric, R. Hanemaaijer, J. Newcombe, N.A. van Lent, C.F. Sier, and M.L. Cuzner Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage Brain 124 2001 1978 1988
73. H. Hardin-Pouzet, M. Krakowski, L. Bourbonniere, M. Didier-Bazes, E. Tran, and T. Owens Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis Glia 20 1997 79 85
74. H.P. Hartung, B. Schafer, K. Heininger, and K.V. Toyka Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase Ann. Neurol. 23 1988 453 460
75. S.L. Hauser, A.K. Bhan, F. Gilles, M. Kemp, C. Kerr, and H.L. Weiner Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions Ann. Neurol. 19 1986 578 587
76. B.P. He, W. Wen, and M.J. Strong Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro J. Neuroimmunol. 128 2002 31 38
77. J.J.A. Hendriks, J. Alblas, S.M.A. van der Pol, E.A.F. van Tol, C.D. Dijkstra, and H.E. de Vries Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis J. Exp. Med. 200 2004 1667 1672
78. K. Hensley, K.A. Robinson, S.P. Gabbita, S. Salsman, and R.A. Floyd Reactive oxygen species, cell signaling, and cell injury Free Radic. Biol. Med. 28 2000 1456 1462
79. N. Hikawa, and T. Takenaka Myelin-stimulated macrophages release neurotrophic factors for adult dorsal root ganglion neurons in culture Cell Mol. Neurobiol. 16 1996 517 528
80. W.F. Holt Glutamate in health and disease: the role of inhibitors P.R. Bär L. Flint Beal Neuroprotection in CNS Diseases 1997 Marcel Dekker Inc New York 87 119
81. D.C. Hooper, S.T. Ohnishi, R. Kean, Y. Numagami, B. Dietzschold, and H. Koprowski Local nitric oxide production in viral and autoimmune diseases of the central nervous system Proc. Natl. Acad. Sci. U. S. A 92 1995 5312 5316
82. D.C. Hooper, G.S. Scott, A. Zborek, T. Mikheeva, R.B. Kean, H. Koprowski, and S.V. Spitsin Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis FASEB J. 14 2000 691 698
83. I. Huitinga, N. van Rooijen, C.J. De Groot, B.M. Uitdehaag, and C.D. Dijkstra Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages J. Exp. Med. 172 1990 1025 1033
84. M.I. Hunter, B.C. Nlemadim, and D.L. Davidson Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients Neurochem. Res. 10 1985 1645 1652
85. G.H. Jeohn, L.Y. Kong, B. Wilson, P. Hudson, and J.S. Hong Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures J. Neuroimmunol. 85 1998 1 10
86. R. Kapoor, M. Davies, P.A. Blaker, S.M. Hall, and K.J. Smith Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration Ann. Neurol. 53 2003 174 180
87. R.B. Kean, S.V. Spitsin, T. Mikheeva, G.S. Scott, and D.C. Hooper The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity J. Immunol. 165 2000 6511 6518
88. J. Killestein, M.J. Eikelenboom, T. Izeboud, N.F. Kalkers, H.J. Ader, F. Barkhof, R.A. Van Lier, B.M. Uitdehaag, and C.H. Polman Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS J. Neuroimmunol. 142 2003 141 148
89. E.H. Koo, S.S. Sisodia, D.R. Archer, L.J. Martin, A. Weidemann, K. Beyreuther, P. Fischer, C.L. Masters, and D.L. Price Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport Proc. Natl. Acad. Sci. U. S. A. 87 1990 1561 1565
90. B. Kornek, M.K. Storch, R. Weissert, E. Wallstroem, A. Stefferl, T. Olsson, C. Linington, M. Schmidbauer, and H. Lassmann Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions Am. J. Pathol. 157 2000 267 276
91. B. Kornek, M.K. Storch, J. Bauer, A. Djamshidian, R. Weissert, E. Wallstroem, A. Stefferl, F. Zimprich, T. Olsson, C. Linington, M. Schmidbauer, and H. Lassmann Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis Brain 124 2001 1114 1124
92. J. Kraus, B.S. Kuehne, J. Tofighi, P. Frielinghaus, E. Stolz, F. Blaes, C. Laske, B. Engelhardt, H. Traupe, M. Kaps, and P. Oschmann Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis Acta Neurol. Scand. 105 2002 300 308
93. P. Kubes, M. Suzuki, and D.N. Granger Nitric oxide: an endogenous modulator of leukocyte adhesion Proc. Natl. Acad. Sci. U. S. A 88 1991 4651 4655
94. T. Kuhlmann, G. Lingfeld, A. Bitsch, J. Schuchardt, and W. Bruck Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time Brain 125 2002 2202 2212
95. D. Leppert, R.L. Lindberg, L. Kappos, and S.L. Leib Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis Brain Res. Brain Res. Rev. 36 2001 249 257
96. S. Li, and P.K. Stys Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter J. Neurosci. 20 2000 1190 1198
97. G.L. Li, M. Farooque, A. Holtz, and Y. Olsson Changes of beta-amyloid precursor protein after compression trauma to the spinal cord: an experimental study in the rat using immunohistochemistry J. Neurotrauma 12 1995 269 277
98. R.L. Lindberg, C.J. De Groot, L. Montagne, P. Freitag, P. van der Valk, L. Kappos, and D. Leppert The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis Brain 124 2001 1743 1753
99. Y. Liu, B. Zhu, X. Wang, L. Luo, P. Li, D.W. Paty, and M.S. Cynader Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis J. Neuroimmunol. 139 2003 27 35
100. N.A. Losseff, D.P. Kingsley, W.I. McDonald, D.H. Miller, and A.J. Thompson Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis Mult. Scler. 1 1996 218 222
101. F. Lu, M. Selak, J. OConnor, S. Croul, C. Lorenzana, C. Butunoi, and B. Kalman Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis J. Neurol. Sci. 177 2000 95 103
102. W. Lu, M. Bhasin, and S.E. Tsirka Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis J. Neurosci. 22 2002 10781 10789
103. J.D. MacMicking, D.O. Willenborg, M.J. Weidemann, K.A. Rockett, and W.B. Cowden Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells J. Exp. Med. 176 1992 303 307
104. G. Mancardi, B. Hart, L. Roccatagliata, H. Brok, D. Giunti, R. Bontrop, L. Massacesi, E. Capello, and A. Uccelli Demyelination and axonal damage in a non-human primate model of multiple sclerosis J. Neurol. Sci. 184 2001 41 49
105. A. Mantovani, T. Schioppa, S.K. Biswas, F. Marchesi, P. Allavena, and A. Sica Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations Tumori 89 2003 459 468
106. G.H. Marracci, R.E. Jones, G.P. McKeon, and D.N. Bourdette Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis J. Neuroimmunol. 131 2002 104 114
107. P.M. Matthews, E. Pioro, S. Narayanan, N. De Stefano, L. Fu, G. Francis, J. Antel, C. Wolfson, and D.L. Arnold Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy Brain 119 Pt. 3 1996 715 722
108. P.M. Matthews, N. De Stefano, S. Narayanan, G.S. Francis, J.S. Wolinsky, J.P. Antel, and D.L. Arnold Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis Semin. Neurol. 18 1998 327 336
109. C. Matute, M.V. Sanchez-Gomez, L. Martinez-Millan, and R. Miledi Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes Proc. Natl. Acad. Sci. U. S. A. 94 1997 8830 8835
110. J.W. McDonald, S.P. Althomsons, K.L. Hyrc, D.W. Choi, and M.P. Goldberg Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity Nat. Med. 4 1998 291 297
111. I.M. Medana, A. Gallimore, A. Oxenius, M.M. Martinic, H. Wekerle, and H. Neumann MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway Eur. J. Immunol. 30 2000 3623 3633
112. C. Miller, O. Tsatas, and S. David Dibutyryl cAMP, interleukin-1 beta, and macrophage conditioned medium enhance the ability of astrocytes to promote neurite growth J. Neurosci. Res. 38 1994 56 63
113. M.A. Munoz-Fernandez, and M. Fresno The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system Prog. Neurobiol. 56 1998 307 340
114. P.D. Murray, D.B. McGavern, X. Lin, M.K. Njenga, J. Leibowitz, L.R. Pease, and M. Rodriguez Perforin-dependent neurologic injury in a viral model of multiple sclerosis J. Neurosci. 18 1998 7306 7314
115. R. Naidoo, and M.L. Knapp Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions Clin. Chem. 38 1992 2449 2454
116. F.E. Nashold, D.J. Miller, and C.E. Hayes 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis J. Neuroimmunol. 103 2000 171 179
117. H. Neumann The immunological microenvironment in the CNS: implications on neuronal cell death and survival J. Neural Transm., Suppl. 59 2000 59 68
118. H. Neumann, A. Cavalie, D.E. Jenne, and H. Wekerle Induction of MHC class I genes in neurons Science 269 1995 549 552
119. H. Neumann, H. Schmidt, A. Cavalie, D. Jenne, and H. Wekerle Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha J. Exp. Med. 185 1997 305 316
120. J. Newcombe, S. Gahan, and M.L. Cuzner Serum antibodies against central nervous system proteins in human demyelinating disease Clin. Exp. Immunol. 59 1985 383 390
121. T.A. Newman, S.T. Woolley, P.M. Hughes, N.R. Sibson, D.C. Anthony, and V.H. Perry T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases Brain 124 2001 2203 2214
122. A. Nicot, P.V. Ratnakar, Y. Ron, C.C. Chen, and S. Elkabes Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction Brain 126 2003 398 412
123. A.S. Nimnual, L.J. Taylor, and D. Bar-Sagi Redox-dependent downregulation of Rho by Rac Nat. Cell Biol. 5 2003 236 241
124. N.C. OBrien, B. Charlton, W.B. Cowden, and D.O. Willenborg Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease J. Immunol. 167 2001 5904 5912
125. M. Ohgoh, T. Hanada, T. Smith, T. Hashimoto, M. Ueno, Y. Yamanishi, M. Watanabe, and Y. Nishizawa Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis J. Neuroimmunol. 125 2002 170 178
126. A. Oka, M.J. Belliveau, P.A. Rosenberg, and J.J. Volpe Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention J. Neurosci. 13 1993 1441 1453
127. E.L. Oleszak, E. Zaczynska, M. Bhattacharjee, C. Butunoi, A. Legido, and C.D. Katsetos Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis Clin. Diagn. Lab. Immunol. 5 1998 438 445
128. H. Onodera, I. Nakashima, K. Fujihara, T. Nagata, and Y. Itoyama Elevated plasma level of plasminogen activator inhibitor-1 (PAI-1) in patients with relapsing-remitting multiple sclerosis Tohoku J. Exp. Med. 189 1999 259 265
129. A. Paolillo, C. Pozzilli, C. Gasperini, E. Giugni, C. Mainero, S. Giuliani, V. Tomassini, E. Millefiorini, and S. Bastianello Brain atrophy in relapsing-remitting multiple sclerosis: relationship with black holes, disease duration and clinical disability J. Neurol. Sci. 174 2000 85 91
130. J.F. Parkinson, B. Mitrovic, and J.E. Merrill The role of nitric oxide in multiple sclerosis J. Mol. Med. 75 1997 174 186
131. M.P. Pender Demyelination and neurological signs in experimental allergic encephalomyelitis J. Neuroimmunol. 15 1987 11 24
132. M. Penkowa, and J. Hidalgo Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis J. Neurosci. Res. 72 2003 574 586
133. M. Penkowa, C. Espejo, E.M. Martinez-Caceres, C.B. Poulsen, X. Montalban, and J. Hidalgo Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis J. Neuroimmunol. 119 2001 248 260
134. D. Piani, and A. Fontana Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons J. Immunol. 152 1994 3578 3585
135. D. Piani, K. Frei, K.Q. Do, M. Cuenod, and A. Fontana Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate Neurosci. Lett. 133 1991 159 162
136. D. Piani, K. Frei, H.W. Pfister, and A. Fontana Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor J. Neuroimmunol. 48 1993 99 104
137. J.E. Pierce, J.Q. Trojanowski, D.I. Graham, D.H. Smith, and T.K. McIntosh Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat J. Neurosci. 16 1996 1083 1090
138. D. Pitt, P. Werner, and C.S. Raine Glutamate excitotoxicity in a model of multiple sclerosis Nat. Med. 6 2000 67 70
139. D. Pitt, I.E. Nagelmeier, H.C. Wilson, and C.S. Raine Glutamate uptake by oligodendrocytes: implications for excitotoxicity in multiple sclerosis Neurology 61 2003 1113 1120
140. Z. Qiu, D.D. Sweeney, J.G. Netzeband, and D.L. Gruol Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons J. Neurosci. 18 1998 10445 10456
141. M.N. Rasband, T. Kagawa, E.W. Park, K. Ikenaka, and J.S. Trimmer Dysregulation of axonal sodium channel isoforms after adult-onset chronic demyelination J. Neurosci. Res. 73 2003 465 470
142. J.A. Rawes, V.P. Calabrese, O.A. Khan, and G.H. DeVries Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases Mult. Scler. 3 1997 363 369
143. E.J. Redford, R. Kapoor, and K.J. Smith Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible Brain 120 Pt. 12 1997 2149 2157
144. A. Rensing-Ehl, U. Malipiero, M. Irmler, J. Tschopp, D. Constam, and A. Fontana Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway Eur. J. Immunol. 26 1996 2271 2274
145. C. Rivera-Quinones, D. McGavern, J.D. Schmelzer, S.F. Hunter, P.A. Low, and M. Rodriguez Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis Nat. Med. 4 1998 187 193
146. J.W. Rose, K.E. Hill, Y. Wada, C.I. Kurtz, I. Tsunoda, R.S. Fujinami, and A.H. Cross Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theilers virus infection J. Neuroimmunol. 81 1998 82 89
147. N. Rothwell, S. Allan, and S. Toulmond The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications J. Clin. Invest. 100 1997 2648 2652
148. S.R. Ruuls, J. Bauer, K. Sontrop, I. Huitinga, B.A. t Hart, and C.D. Dijkstra Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats J. Neuroimmunol. 56 1995 207 217
149. S.R. Ruuls, L.S. Van Der, K. Sontrop, I. Huitinga, and C.D. Dijkstra Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors Clin. Exp. Immunol. 103 1996 467 474
150. P. Sacerdote, P. Massi, A.E. Panerai, and D. Parolaro In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors J. Neuroimmunol. 109 2000 155 163
151. B.T. Sadatipour, J.M. Greer, and M.P. Pender Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis Ann. Neurol. 44 1998 980 983
152. P. Sarchielli, L. Greco, A. Floridi, A. Floridi, and V. Gallai Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid Arch. Neurol. 60 2003 1082 1088
153. K.W. Selmaj, and C.S. Raine Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro Ann. Neurol. 23 1988 339 346
154. S. Shamash, F. Reichert, and S. Rotshenker The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta J. Neurosci. 22 2002 3052 3060
155. F.E. Sherriff, L.R. Bridges, and S. Sivaloganathan Early detection of axonal injury after human head trauma using immunocytochemistry for beta-amyloid precursor protein Acta Neuropathol. (Berl) 87 1994 55 62
156. H. Siebert, and W. Bruck The role of cytokines and adhesion molecules in axon degeneration after peripheral nerve axotomy: a study in different knockout mice Brain Res. 960 2003 152 156
157. M.L. Simmons, C.G. Frondoza, and J.T. Coyle Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies Neuroscience 45 1991 37 45
158. T. Smith, A. Groom, B. Zhu, and L. Turski Autoimmune encephalomyelitis ameliorated by AMPA antagonists Nat. Med. 6 2000 62 66
159. K.J. Smith, R. Kapoor, S.M. Hall, and M. Davies Electrically active axons degenerate when exposed to nitric oxide Ann. Neurol. 49 2001 470 476
160. S.V. Spitsin, G.S. Scott, T. Mikheeva, A. Zborek, R.B. Kean, C.M. Brimer, H. Koprowski, and D.C. Hooper Comparison of uric acid and ascorbic acid in protection against EAE Free Radical Biol. Med. 33 2002 1363 1371
161. R. Stanislaus, A.K. Singh, and I. Singh Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis J. Neurosci. Res. 66 2001 155 162
162. L.A. Sternberger, and N.H. Sternberger Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ Proc. Natl. Acad. Sci. U. S. A. 80 1983 6126 6130
163. V.C. Stewart, J.M. Land, J.B. Clark, and S.J. Heales Pretreatment of astrocytes with interferon-alpha/beta prevents neuronal mitochondrial respiratory chain damage J. Neurochem. 70 1998 432 434
164. L.A. Stone, J.A. Frank, P.S. Albert, C.N. Bash, P.A. Calabresi, H. Maloni, and H.F. McFarland Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure Neurology 49 1997 862 869
165. J.F. Stover, K. Lowitzsch, and O.S. Kempski Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases Neurosci. Lett. 238 1997 25 28
166. P.K. Stys, and H. Lesiuk Correlation between electrophysiological effects of mexiletine and ischemic protection in central nervous system white matter Neuroscience 71 1996 27 36
167. P.K. Stys, B.R. Ransom, and S.G. Waxman Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability J. Neurophysiol. 67 1992 236 240
168. J.L. Takahashi, F. Giuliani, C. Power, Y. Imai, and V.W. Yong Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity Ann. Neurol. 53 2003 588 595
169. J. Tan, T. Town, D. Paris, A. Placzek, T. Parker, F. Crawford, H. Yu, J. Humphrey, and M. Mullan Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis J. Neuroimmunol. 97 1999 77 85
170. D.L. Taylor, S.E. Davies, T.P. Obrenovitch, M.H. Doheny, P.N. Patsalos, J.B. Clark, and L. Symon Investigation into the role of N-acetylaspartate in cerebral osmoregulation J. Neurochem. 65 1995 275 281
171. T. Teesalu, A.E. Hinkkanen, and A. Vaheri Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice Am. J. Pathol. 159 2001 2227 2237
172. T. Touil, M.S. Deloire-Grassin, C. Vital, K.G. Petry, and B. Brochet In vivo damage of CNS myelin and axons induced by peroxynitrite NeuroReport 12 2001 3637 3644
173. S. Toulmond, X. Vige, D. Fage, and J. Benavides Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons Neurosci. Lett. 144 1992 49 52
174. B.D. Trapp, J. Peterson, R.M. Ransohoff, R. Rudick, S. Mork, and L. Bo Axonal transection in the lesions of multiple sclerosis N. Engl. J. Med. 338 1998 278 285
175. P. van der Valk, and C.J. De Groot Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS Neuropathol. Appl. Neurobiol. 26 2000 2 10
176. R.C. van der Veen, D.R. Hinton, F. Incardonna, and F.M. Hofman Extensive peroxynitrite activity during progressive stages of central nervous system inflammation J. Neuroimmunol. 77 1997 1 7
177. B.W. van Oosten, F. Barkhof, L. Truyen, J.B. Boringa, F.W. Bertelsmann, B.M. von Blomberg, J.N. Woody, H.P. Hartung, and C.H. Polman Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 Neurology 47 1996 1531 1534
178. M.A. van Walderveen, W. Kamphorst, P. Scheltens, J.H. van Waesberghe, R. Ravid, J. Valk, C.H. Polman, and F. Barkhof Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis Neurology 50 1998 1282 1288
179. O. Vladimirova, F.M. Lu, L. Shawver, and B. Kalman The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls Inflammation Res. 48 1999 412 416
180. A. Volterra, D. Trotti, C. Tromba, S. Floridi, and G. Racagni Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes J. Neurosci. 14 1994 2924 2932
181. P. Werner, D. Pitt, and C.S. Raine Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage Ann. Neurol. 50 2001 169 180
182. D.O. Willenborg, M.A. Staykova, and W.B. Cowden Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review J. Neuroimmunol. 100 1999 21 35
183. J.R. Wujek, C. Bjartmar, E. Richer, R.M. Ransohoff, M. Yu, V.K. Tuohy, and B.D. Trapp Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis J. Neuropathol. Exp. Neurol. 61 2002 23 32
184. L.Y. Xu, J.S. Yang, H. Link, and B.G. Xiao SIN-1, a nitric oxide donor, ameliorates experimental allergic encephalomyelitis in Lewis rats in the incipient phase: the importance of the time window J. Immunol. 166 2001 5810 5816
185. P.S. Yam, J. Patterson, D.I. Graham, T. Takasago, D. Dewar, and J. McCulloch Topographical and quantitative assessment of white matter injury following a focal ischaemic lesion in the rat brain Brain Res. Brain Res. Protoc. 2 1998 315 322
186. V.W. Yong, C. Power, P. Forsyth, and D.R. Edwards Metalloproteinases in biology and pathology of the nervous system Nat. Rev., Neurosci. 2 2001 502 511
187. N. Zerangue, J.L. Arriza, S.G. Amara, and M.P. Kavanaugh Differential modulation of human glutamate transporter subtypes by arachidonic acid J. Biol. Chem. 270 1995 6433 6435
188. G.X. Zhang, C.M. Baker, D.L. Kolson, and A.M. Rostami Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis Mult. Scler. 6 2000 3 13
189. B. Zhu, L. Luo, G.R. Moore, D.W. Paty, and M.S. Cynader Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis Am. J. Pathol. 162 2003 1639 1650